Botulinum neurotoxin for pain management: Insights from animal models

Flaminia Pavone, Siro Luvisetto

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The action of botulinum neurotoxins (BoNTs) at the neuromuscular junction has been extensively investigated and knowledge gained in this field laid the foundation for the use of BoNTs in human pathologies characterized by excessive muscle contractions. Although much more is known about the action of BoNTs on the peripheral system, growing evidence has demonstrated several effects also at the central level. Pain conditions, with special regard to neuropathic and intractable pain, are some of the pathological states that have been recently treated with BoNTs with beneficial effects. The knowledge of the action and potentiality of BoNTs utilization against pain, with emphasis for its possible use in modulation and alleviation of chronic pain, still represents an outstanding challenge for experimental research. This review highlights recent findings on the effects of BoNTs in animal pain models.

Original languageEnglish
Pages (from-to)2890-2913
Number of pages24
JournalToxins
Volume2
Issue number12
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Neurotoxins
Pain Management
Animals
Animal Models
Pain
Intractable Pain
Neuromuscular Junction
Neuralgia
Pathology
Muscle Contraction
Chronic Pain
Muscle
Modulation
Research

Keywords

  • Analgesia
  • Animal model
  • Botulinum toxin
  • Central sensitization
  • Chronic pain
  • Inflammatory pain
  • Pain
  • Peripheral sensitization
  • Retrograde axonal transport
  • SNARE

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Botulinum neurotoxin for pain management : Insights from animal models. / Pavone, Flaminia; Luvisetto, Siro.

In: Toxins, Vol. 2, No. 12, 12.2010, p. 2890-2913.

Research output: Contribution to journalArticle

Pavone, Flaminia ; Luvisetto, Siro. / Botulinum neurotoxin for pain management : Insights from animal models. In: Toxins. 2010 ; Vol. 2, No. 12. pp. 2890-2913.
@article{2a5304bad3394c9ba6244a3f22b11932,
title = "Botulinum neurotoxin for pain management: Insights from animal models",
abstract = "The action of botulinum neurotoxins (BoNTs) at the neuromuscular junction has been extensively investigated and knowledge gained in this field laid the foundation for the use of BoNTs in human pathologies characterized by excessive muscle contractions. Although much more is known about the action of BoNTs on the peripheral system, growing evidence has demonstrated several effects also at the central level. Pain conditions, with special regard to neuropathic and intractable pain, are some of the pathological states that have been recently treated with BoNTs with beneficial effects. The knowledge of the action and potentiality of BoNTs utilization against pain, with emphasis for its possible use in modulation and alleviation of chronic pain, still represents an outstanding challenge for experimental research. This review highlights recent findings on the effects of BoNTs in animal pain models.",
keywords = "Analgesia, Animal model, Botulinum toxin, Central sensitization, Chronic pain, Inflammatory pain, Pain, Peripheral sensitization, Retrograde axonal transport, SNARE",
author = "Flaminia Pavone and Siro Luvisetto",
year = "2010",
month = "12",
doi = "10.3390/toxins2122890",
language = "English",
volume = "2",
pages = "2890--2913",
journal = "Toxins",
issn = "2072-6651",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Botulinum neurotoxin for pain management

T2 - Insights from animal models

AU - Pavone, Flaminia

AU - Luvisetto, Siro

PY - 2010/12

Y1 - 2010/12

N2 - The action of botulinum neurotoxins (BoNTs) at the neuromuscular junction has been extensively investigated and knowledge gained in this field laid the foundation for the use of BoNTs in human pathologies characterized by excessive muscle contractions. Although much more is known about the action of BoNTs on the peripheral system, growing evidence has demonstrated several effects also at the central level. Pain conditions, with special regard to neuropathic and intractable pain, are some of the pathological states that have been recently treated with BoNTs with beneficial effects. The knowledge of the action and potentiality of BoNTs utilization against pain, with emphasis for its possible use in modulation and alleviation of chronic pain, still represents an outstanding challenge for experimental research. This review highlights recent findings on the effects of BoNTs in animal pain models.

AB - The action of botulinum neurotoxins (BoNTs) at the neuromuscular junction has been extensively investigated and knowledge gained in this field laid the foundation for the use of BoNTs in human pathologies characterized by excessive muscle contractions. Although much more is known about the action of BoNTs on the peripheral system, growing evidence has demonstrated several effects also at the central level. Pain conditions, with special regard to neuropathic and intractable pain, are some of the pathological states that have been recently treated with BoNTs with beneficial effects. The knowledge of the action and potentiality of BoNTs utilization against pain, with emphasis for its possible use in modulation and alleviation of chronic pain, still represents an outstanding challenge for experimental research. This review highlights recent findings on the effects of BoNTs in animal pain models.

KW - Analgesia

KW - Animal model

KW - Botulinum toxin

KW - Central sensitization

KW - Chronic pain

KW - Inflammatory pain

KW - Pain

KW - Peripheral sensitization

KW - Retrograde axonal transport

KW - SNARE

UR - http://www.scopus.com/inward/record.url?scp=79952097579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952097579&partnerID=8YFLogxK

U2 - 10.3390/toxins2122890

DO - 10.3390/toxins2122890

M3 - Article

C2 - 22069581

AN - SCOPUS:79952097579

VL - 2

SP - 2890

EP - 2913

JO - Toxins

JF - Toxins

SN - 2072-6651

IS - 12

ER -